NASDAQ · LITSHealthcarePharmaceuticals

Lite Strategy financials

$1.38+1.10%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY26
Jun 30
Revenue$0.00
Gross profit$0.00
Gross margin—
Operating income-$66.6M
Net income-$71.2M
Net margin—
Diluted EPS$-2.06
EBITDA-$66.6M
Operating cash flow-$9.1M
Free cash flow-$9.1M
Diluted shares34.6M

Balance sheet

Period endJun 30
Cash & equivalents$5.7M
Short-term investments$0.00
Total debt$0.00
Total assets$42.7M
Total liabilities$1.1M
Shareholders' equity$41.6M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology